ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

National Cancer Act Creates Expectation Of Independence, Leads To Conflict With NIH, Broder Says

January 20, 1995

California Cancer Research Program Seeks Non-Resident Survivor Reviewers.

May 25, 2001

HHS, NIH Prepare for Government Shutdown

September 20, 2013

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991

NCAB To Hear Program Reviews, Try Again On Act Revisions

October 22, 1976

What the Physician Pay Report Won’t Tell You

April 11, 2014